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Abstract 
 
Background: HTLV-1 infection is endemic in Mashhad, Northeast of Iran. This study was designed to assess 
the epidemiology of HTLV-1 and potential risk factors in Neyshabour, Northeastern Iran. 
 
Methods: All those who referred to Iranian Academic Center for Education, Culture and Research (ACECR)-
Mashhad Laboratory in Neyshabour for evaluation of HTLV-I by ELISA, were tested using WB if the ELISA result 
was positive. A questionnaire about risk factors of infection was completed for all cases.  
 
Results: HTLV-1 infection was positive in 7.2% (35/483) of the participants according to the results of enzyme-
linked immunosorbent assay (ELISA) and western blot (WB) tests. Infection was significantly associated with 
age, family size, income and blood transfusion. However, gender, education, birthplace, race, marital status, and 
history of surgery, dentistry, traditional cupping, and hospitalization showed no significant relation.  
 
Conclusion: It seems that HTLV-I infection is highly endemic in Neyshabour and it is seems that more effective 
treatment strategies are needed. 
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Introduction 
 
Human T Lymphotrophic Virus type I (HTLV-I), a 
Deltavirus member of Retroviridae family has a cos-
mopolitan distribution and currently more than 20 
million people in the world are infected with this vi-
rus.
1 Prevalence rate of more than 1% in the general 
population, Caribbean Basin, Central Africa, and 
South Japan are assumed as an endemic area for 
HTLV-I.
2 Northeast of Iran, Mashhad, the capital of 
Razavi Khorasan Province, is endemic for HTLV 
with a prevalence of 3% among general population.
3 
In 2002, screening by enzyme-linked immunosorbent 
assay (ELISA) test for evaluation of HTLV infection 
revealed a prevalence of 3.4% in general population 
of Neyshabour, as the third largest city of the province.
4 
However, confirming of the results by western blot 
(WB) was not performed in that study, and the pre-
cise prevalence of HTLV infection in this city is not 
determined yet. This study aims to evaluate the preva-
lence of HTLV infection and the sociodemographic 
and other potential risk factors among those who re-
ferred to Iranian Academic Center for Education, Cul-
ture and Research (ACECR)-Mashhad Clinical La-
boratory in the city of Neyshabour, Northeastern Iran 
for the evaluation of HTLV-I.  
 
 
Materials and Methods  
 
From February to August 2009 in a non-random sam-
pling and a cross-sectional descriptive-analytic study, 
all those who referred to ACECR-Mashhad Clinical 
Lab in Neyshabour, Northeastern Iran for the evalua-
tion of HTLV-1 infection (n=511) were enrolled. Af-
ter a thorough explanation of the research project and 
invitation to participate in the study, a questionnaire 
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on demographic features and potential risk factors of 
the infection such as a history of blood transfusion, 
surgery, dentistry procedures, being hospitalized, tra-
ditional cupping, and tattooing was completed for 
each case. Also an informed consent was obtained 
from each participant. After testing the blood samples 
by ELISA (ELISA-4; Dia. Pro diagnostic Bioprobes, 
Italy), which was ordered by physicians of the city, 
WB analysis (HTLV blot 2.4 kit, MP diagnostic Ltd., 
Germany) was used for the confirmation of positive 
ELISA results. Criteria for HTLV-I sero-positivity in 
WB test was reactivity to GAG (p19 with or without 
p24) and two ENV (GD21 and rgp 46-I) proteins. 
Data were analyzed using SPSS software (Version 
13.0, Chicago, IL, USA) by Chi-Square and t tests. P 
values <0.05 were considered statistically significant. 
 
 
Results  
 
The mean age of participants was 37.4±15.4 years 
(Range: 5-84 years). Four hundred and four cases 
(79.1%) were female, 94.9% were at least once mar-
ried, 86.7% were born in Razavi Khorasan Province 
and 96.6% had Fars ethnicity. 27.6% lived in a small 
family size (≤2) and 27.2% in a large family size 
(>5). Also 14.9% were illiterate, 36.4% had 1-8 years 
of education, 30.8% had 9-12 years of education, and 
17.9% had an academic educational level. Among the 
participants, 12.9% were governmental employee, 
17.6% non-governmental, 5.0% student, and 64.5% 
were unemployed. 60.6% had less than 300 US$ 
monthly income, 33.2%, 300-500 US$, and 6.3% 
more than 500 US$. Pregnancy was the main reason 
(28.4%, 145/511) for which the participants were re-
ferred to the lab for evaluation of HTLV-1 infection. 
Other reasons were the patient’s request (21.7%, 
111/511), being candidate for an operation (9%, 
46/511), presence of indicative symptoms in patients 
(7.4%, 38/511), a positive history of the infection in 
at least one of the family members (2.2%, 11/511), 
and other reasons (4.1%, 21/511). The reason for pa-
tient’s referral was not determined in 139 cases 
(27.2%).  History of blood transfusion was noticed in 
4.6%, surgery in 39.4%, traditional cupping in 8.0%, 
dentistry procedures in 18.9%, hospitalization in 
31.5%, tattooing in 1.2%, and imprisonment in 0.6% 
of the participants.  
ELISA was positive in 62 (12.1%) and 3 patients 
(0.6%) had borderline results. Among these two 
groups, WB analysis was performed for 37 cases (28 
did not agree to perform WB). The WB result was pos-
itive in 94.6% (35/37); however the result was inde-
terminate in one case. Overall prevalence of HTLV 
infection was 7.2% (35/483) based on ELISA and WB 
results. Infection was significantly correlated with age 
(p<0.001), family size (p=0.004), income (p<0.001) 
and history of blood transfusion (p=0.024) (Table 1 
and 2).  Age was the most important factor which had 
the highest impact on the infection (OR= 8.05). 
Table 1: Comparison of demographic features of HTLV positive and negative cases 
   No.  Positive cas-
es (%)  Odd Ratio  95% CI  P value 
Age  <30   197  3 (1.5)  8.05 2.43-26.73  <0.001  ≥30 280  31  (11.1) 
Sex  Male   97  10 (10.3)  0.60 0.28-1.31    0.196  Female   385  25 (6.5) 
Birth place  Khorasan Razavi   422  32 (7.6)  0.61 0.08-4.69    0.631  Other provinces   21  1 (4.8) 
Race  Fars 407  29  (7.1)  0.93 0.12-7.33    0.946  Others 15  1  (6.7) 
Marital status  Married   418 26 (6.2) 2.60 0.93-7.27    0.060  Non-married 34  5  (14.7) 
Family size  ≤2   114  2 (1.8)  6.42 1.51-27.37    0.004  >2   282 29 (10.3)
Education  0-8 years  223  21 (9.4)  0.50   0.24-1.07   0.070  ≥9 years   221  11 (5.0) 
Job  Employed/Retired 126  12  (9.5)  0.71 0.34-1.51    0.337  Non-employed 286 20  (7.0) 
Income (Monthly)  <300 US $   224  7 (3.1)  5.22 2.15-12.60  <0.001  ≥300 US $  146  21 (14.4) Hedayati-Moghaddam et al. 
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Discussion 
 
Areas with sero-prevalence of more than 2% are cate-
gorized as high endemic regions.
5 The current study 
showed a high prevalence of HTLV-I infection in a 
non-random sample of Neyshabour population. The 
high seroprevalence of HTLV infection by ELISA test 
had been previously shown in some studies. In 2002, 
Farid  et al. revealed that the HTLV prevalence was 
3.4% in the general population of Neyshabour.
4 HTLV 
infection is mainly localized in northeast of Iran in-
cluding Mashhad and neighbor cities, and studies in 
several other areas, which are predominantly carried on 
blood donors demonstrated a lower prevalence from 
0.01% to 0.62%.
6-8 On the other hand, many studies 
have shown that HTLV infection in high risk groups 
such as multitransfused patients throughout the country 
is more prevalent (1%-6.8%).
6,8-12  
High prevalence of HTLV-1 infection found in this 
study might be due to a possible higher risk of infection 
in this sample, because our cases were referred for eval-
uation of HTLV by physicians of the city. There was a 
correlation between referral reasons and HTLV-1 sero-
positivity. Pregnancy was the main reason for referral 
(28.4%). The prevalence of the infection among preg-
nant women in our study was 1.39% which was a little 
higher than the same prevalence among pregnant wom-
en in Mashhad (0.9%).
13 Nevertheless, screening of 
HTLV infection by ELISA is not included in the nation-
al program of pre-natal care, but physicians refer preg-
nant women for HTLV serology test. However, HTLV 
screening is performed regularly in the blood donors of 
Khorasan provinces (North, South and Razavi) accord-
ing to the guidelines of “Iranian Blood Ttransfusion Or-
ganization”.
14 In our study, 9% of the participants were 
referred by a surgeon for the evaluation of HTLV infec-
tion prior to the surgical operations which seems to be-
come a common reason for referral. The results of our 
study showed that the prevalence of the infection in pa-
tients who had been referred by a physician for screen-
ing (surgery/pregnancy) is relatively low, so it would be 
more efficient to only refer high risk or suspected cases 
for the screening. 
In this study, the correlation between some of the 
demographic features including age, family size, and 
income and HTLV infection was significant. Howev-
er, birthplace, race, marital status, job, and literacy 
level did not have a significant impact on the infec-
tion. Several other studies represented age to have 
correlation with the infection.
15,16 In evaluation of risk 
factors for HTLV sero-positivity, Murphy et al. 
showed no association between HTLV-I sero-
positivity and educational attainment, income or occu-
pation.
17 However, education and ethnic affiliations 
were shown to have a relation with the infection.
15,18,19 
On the other hand, there are some studies, presenting 
exactly the opposite results. A study in Panama 
demonstrated that race and socioeconomic factors were 
not associated with infection.
20 Thus, it seems that sev-
eral other factors such as cultural and other demo-
graphic differences probably affect these associations.  
None of the potential non-sociodemographic risk 
factors of the infection including history of surgery, 
dentistry procedures, traditional cupping and hospital-
ization was found to be associated with the infection. 
However, our study is in consistent with several in-
vestigations and showed that blood transfusion had a 
correlation with HTLV infection.
15,21,22 
As a conclusion, high prevalence of HTLV-1 in-
fection, which was clearly shown in the current study, 
Table 2: Comparison of risk factors of HTLV positive and negative cases 
    No. Positive cases (%) Odd Ratio 95% CI  P value
Reasons of referring to 
Lab 
Screening 
a  189    2 (1.1)  15.06 3.50-64.75  <0.001  Non-screening 173 24  (13.9) 
History of blood transfu-
sion 
Positive  31    4 (12.9)  3.50 1.11-11.08  0.024  Negative 443  18  (4.1) 
History of Surgery  Positive 187  16  (8.6)  0.55 0.26-1.16  0.110  Negative 286  14  (4.9) 
History of Dentistry  Positive  93    9 (9.7)  0.57 0.26-1.29  0.174  Negative 380  22  (5.8) 
History of traditional 
cupping 
Positive  38    1 (2.6)  2.64 0.35-19.96  0.328  Negative 435  29  (6.7) 
History of Hospitaliza-
tion 
Positive 149  10  (6.7)  0.91 0.42-2.01  0.823  Negative 324  20  (6.2) 
a Screening included pregnancy and being candidate from operation. HTLV-1 in Northeasern Iran 
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not only approves the previous findings, but also ne-
cessitates more attention and planning for the control 
of the infection in the Northeast of Iran. 
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